Multi-target combination treatment with rTMS and tDCS for Tourette syndrome: a case report

Front Hum Neurosci. 2025 Jan 7:18:1441019. doi: 10.3389/fnhum.2024.1441019. eCollection 2024.

Abstract

Tourette syndrome (TS) is a neuropsychiatric disorder characterized by chronic motor and phonic tics, with a higher prevalence among boys. This condition can significantly impact patients' learning and daily life. Due to the limited efficacy and potential side effects of pharmacological treatments for TS, there is a critical need to develop novel, tailored therapeutic strategies. Repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS) have been proposed as potential treatments for TS, and have shown promising results. Here, we report a case of refractory TS, in which low-frequency rTMS was delivered to the left supplementary motor area (SMA), combined with tDCS targeting the primary motor cortex (M1) and the cerebellum, with the cathode positioned over the right M1 and the anode over the left cerebellum. This is the first reported case using a multi-target combination therapy for TS. This treatment yielded favorable outcomes and maintained good efficacy during a three-month follow-up period. Although larger-scale trials are needed, our findings pave the way for the application of non-invasive brain stimulation techniques in TS, offering a transformative path to improve treatment outcomes and quality of life for those with TS.

Keywords: Tourette syndrome; rTMS; repetitive transcranial magnetic stimulation; tDCS; transcranial direct current stimulation.

Publication types

  • Case Reports

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was supported by the Special scientific and technological research topic of Sichuan Provincial Administration of Traditional Chinese Medicine (2023zd003) and the general incubation project of The Third Hospital of Mianyang (2018).